Previous 10 | Next 10 |
BRIDGEWATER, N.J., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today a poster presentat...
Sintx Technologies (NASDAQ: SINT ) +53% . More news on: Sintx Technologies, Inc., Valeritas Holdings, Inc., MDJM Ltd., Stocks on the move, Read more ...
Nano cap Valeritas Holdings (NASDAQ: VLRX ) is up 41% premarket on average volume in reaction to positive results from a pharmacokinetic study demonstrating "rapid and robust" absorption and distribution of 40 mg of cannabidiol (CBD) over 24 hours with its h-Patch technology. ...
BRIDGEWATER, N.J., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today positive data from...
BRIDGEWATER, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today an oral presentati...
Nano cap Valeritas Holdings (NASDAQ: VLRX ) is up 10% premarket on modest volume in reaction to the results of an investigator-initiated study comparing the delivery of U-100 regular human insulin with the V-Go device with rapid acting insulin with V-Go in type 2 diabeti...
BRIDGEWATER, N.J., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced that a ra...
Valeritas Holdings, Inc. (VLRX) Q2 2019 Earnings Conference Call August 8, 2019 4:30 PM ET Company Participants Greg Chodaczek – Gilmartin Group John Timberlake – President and Chief Executive Officer Erick Lucera – Chief Financial Officer Jessica Barnes ...
Valeritas (NASDAQ: VLRX ): Q2 GAAP EPS of -$2.73 beats by $0.16 . More news on: Valeritas Holdings, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
BRIDGEWATER, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced f...
News, Short Squeeze, Breakout and More Instantly...
BRIDGEWATER, N.J. , Feb. 9, 2020 /PRNewswire/ -- Valeritas Holdings, Inc. (NASDAQ: VLRX) ("Valeritas" or the "Company"), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device , today announced an agreement to sell substantially all of the business to Z...
BRIDGEWATER, N.J., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , today announced revised revenue guida...
BRIDGEWATER, N.J., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced positive data from its pr...